Folate antagonism following teratogenic exposure to diphenylhydantoin
- 1 February 1979
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 19 (1) , 45-49
- https://doi.org/10.1002/tera.1420190108
Abstract
Previous studies have reported indirect evidence for the mediation of folate antagonism in the induction of malformations by diphenylhydantoin. We have demonstrated that a teratogenic regimen of folate-deficiency and antagonism using 9-methyl PGA in the rat produces significantly decreased rates of oxygen consumption in the maldeveloping embryos. The present study reports similar reductions in oxygen uptake by mouse embryos from mothers treated with teratogenic doses of diphenylhydantoin, and documents a significant depression of the actual folate levels in such embryos. The differences are less significant with lower doses of diphenylhydantoin, and do not occur with a nonteratogenic dose.This publication has 15 references indexed in Scilit:
- Respiratory changes in 9-methyl PGA teratogenesisLife Sciences, 1977
- Fetal hydantoin syndromeTeratology, 1976
- ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTSThe Lancet, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- Do Anticonvulsants Have a Teratogenic Effect?Archives of Neurology, 1974
- MATERNAL EPILEPSY AND ABNORMALITIES OF THE FETUS AND NEWBORNThe Lancet, 1972
- Relation of dosage and time of administration of diphenylhydantoin to its teratogenic effect in miceTeratology, 1969
- Methotrexate-induced congenital malformationsThe Journal of Pediatrics, 1968
- Inhibition studies on folic acid metabolism with drugs suspected to act on the myeloproliferative systemClinica Chimica Acta; International Journal of Clinical Chemistry, 1965
- Effect of amines on dihydrofolate reductaseLife Sciences, 1963